Khondrion
mitochondrial disease, small molecule, sonlicromanol
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
mitochondrial disease, small molecule, sonlicromanol
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Khondrion states that mitochondrial diseases are caused by defective mitochondria, which normally act as the cell's powerhouse by producing energy essential for life, and that these disorders are serious, progressive, multi-system illnesses with no available cure; the company says its objective is to develop a cure for patients suffering from mitochondrial diseases through targeted and highly innovative solutions.
SourceKhondrion states that mitochondria are the cell's powerhouses and that cellular energy production is essential for life. It says disturbances in this energy-producing capacity are associated with mitochondrial disease, inborn errors of metabolism, Parkinson's disease, and ageing, and presents its core belief that advancing mitochondrial medicine and modulating cellular energy metabolism can contribute to developing a cure for mitochondrial disease and related disorders.
SourceKhondrion presents mitochondrial disease as a serious, debilitating set of illnesses caused by defective mitochondria, and states that its role is to discover and develop innovative drugs based on deep knowledge of mitochondrial disease and its proprietary technology platform. The company says current care may relieve some clinical problems, but there is still no cure, so it aims to help find one.
SourceKhondrion presents itself as a mitochondrial medicine company devoted to discovering and developing innovative drugs for mitochondrial disease. Its stated view is that mitochondria are essential cellular powerhouses, that defective mitochondria cause a broad range of serious and debilitating illnesses, and that deeper understanding of mitochondrial disease can support the development of treatments, with the ultimate aim of contributing to a cure.
Source